The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
BREA, Calif. , June 3, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") and its charitable arm, the Envista Smile Project, announced today that it has partnered with the Univ...
BREA, Calif. , May 21, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Stifel Jaws & Paws Conference on Wednesday, ...
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024....
Envista Holdings Corporation (NYSE:NVST ) Q1 2024 Earnings Conference Call May 1, 2024 5:00 PM ET Company Participants Stephen Keller - Principal Financial Officer Amir Aghdaei - President and Chief E...
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimate...
Envista (NVST) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.38 per share a year ago....
BREA, Calif. , May 1, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the first quarter of 2024....
BREA, Calif. , April 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) announced today the appointment of Paul Keel as Chief Executive Officer and a member of the Board of Directors e...
BREA, Calif. , April 11, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") announced today that the Envista Smile Project (Smile Project) donated $1.2 million in 2023 as part ...